Skincare Endcap for Pharmacies

Pharmacy dermo-cosmetic (La Roche-Posay, Vichy, Eucerin, CeraVe) is a $15B+ global category growing 8-12% annually, anchored at the intersection of skincare and healthcare retail. Unlike department-store prestige skincare (counter with BA), pharmacy dermo-cosmetic operates unsupervised endcap retail where the 'expert' is the pharmacist 20 meters away at the dispensing counter. This drives specific fixture requirements: pharmacist-call button integration (shopper summons consultation), clinical-detail signage (ingredients, skin concerns, regimen builders), anti-theft for $30-$80 dermo-cosmetic SKUs (higher than mass retail, lower than prestige), and mass-retail unit economics (CVS/Walgreens-scale rollout). Our pharmacy skincare endcap combines all four.